Macugen Market 2026–2035 advancing ophthalmology treatments

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Macugen Market In 2026 And What Value Is Projected For 2030?

Historical growth was driven by a greater incidence of age-related macular degeneration, more frequent detection of diabetic eye conditions, the expansion of specialized ophthalmology clinics, the swift embrace of anti-VEGF treatments, and enhanced capabilities in retinal imaging.

The expansion observed in the forecast period is fueled by an escalating demand for extended-release ocular formulations, rising investments in research concerning retinal diseases, the increasing adoption of personalized ophthalmic treatments, the extension of eye care services for the aging population, and a heightened focus on reducing the frequency of injections.

Key developments anticipated during the forecast period involve the growing application of targeted anti-VEGF therapies, the increasing acceptance of intravitreal injection treatments, an amplified focus on therapies aimed at preserving vision, the expansion of protocols for managing retinal diseases, and an enhanced emphasis on the long-term effectiveness of treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20440&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Macugen Market?

The increasing incidence of age-related macular degeneration (AMD) is projected to boost the expansion of the macugen market in the future. Age-related macular degeneration (AMD) is a progressive eye ailment impacting the macula, the retinal area crucial for sharp and detailed sight. This growing occurrence of age-related macular degeneration (AMD) stems from a globally aging population, longer life expectancies, and lifestyle elements such as smoking, poor nutrition, and extended exposure to ultraviolet (UV) light. Macugen offers advantages for age-related macular degeneration (AMD) by preventing vascular endothelial growth factor (VEGF), which diminishes the formation and leakage of aberrant blood vessels in the retina, thereby aiding in vision preservation and slowing down disease progression. For instance, in May 2023, according to an article published by the National Center for Biotechnology Information, a US-based National Institutes of Health government agency, in 2040, approximately 288 million individuals are projected to be affected by age-related macular degeneration (AMD). Consequently, the rising prevalence of age-related macular degeneration (AMD) is fostering the growth of the macugen market. The increasing emphasis on eye care is poised to stimulate the expansion of the macugen market moving ahead. Eye care encompasses practices and treatments aimed at sustaining or enhancing vision and ocular health. This heightened focus on eye care can be attributed to the growing occurrence of various eye conditions, an aging demographic, and greater recognition of the importance of visual well-being. Macugen proves beneficial for eye care by assisting in the treatment of age-related macular degeneration (AMD) through the suppression of abnormal blood vessel proliferation in the retina, which can avert vision loss and enhance visual sharpness. For instance, in November 2023, according to an article published by Nature, a UK-based journal, in August 2024, according to the Welsh Government, a United Kingdom-based government organization, in 2023-24 the number of sight tests paid for by the NHS in Wales increased to a record high of just over 841,000, representing a 6.6% increase compared to 2022-23. Hence, the heightened focus on eye care is propelling the growth of the macugen market.

What Are The Key Segments Of The Macugen Market?

The macugen market covered in this report is segmented –

1) By Indication: Wet AMD(Age-Related Macular Degeneration (AMD)), Diabetic Macular Edema

2) By Formulation: Intravitreal Injection, Extended-Release Formulations

3) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

4) By End User: Adult Patients, Geriatric Patients

What Key Trends Are Influencing The Development Of The Macugen Market?

A notable trend within the macugen market is the progress in gene therapy. This therapeutic method involves inserting genetic material into a patient’s cells to manage or prevent diseases, with a specific focus on age-related macular degeneration (AMD). For example, in 2023, Regenxbio, a U.S.-based biotechnology company, introduced RGX-314, a gene therapy product engineered to directly deliver a gene encoding an anti-VEGF protein into the eye. This groundbreaking treatment seeks to offer prolonged effects by minimizing the necessity for frequent injections. Key characteristics of RGX-314 include its potential for a one-time administration, which could greatly enhance patient compliance, and its capability to address the fundamental causes of AMD rather than just alleviating symptoms. These developments strategically position companies advantageously within the transforming sector of ocular therapies.

Who Are The Leading Companies Operating In The Macugen Market?

Major companies operating in the macugen market are Bausch + Lomb Inc

Read the full macugen market report here:

https://www.thebusinessresearchcompany.com/report/macugen-global-market-report

What Are The Leading Geographic Regions In The Macugen Market?

North America was the largest region in the macugen market in 2025. The regions covered in the macugen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Macugen Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20440&type=smp

Browse Through More Reports Similar to the Global Macugen Market 2026, By The Business Research Company

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

M Commerce Payment Market Report 2026

https://www.thebusinessresearchcompany.com/report/m-commerce-payment-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795